Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: The DATA-HRpQCT study

Journal of Bone and Mineral Research

Volumn 30, Issue 1, 2015, Pages 39-45

  Tsai, Joy N ^a   Uihlein, Alexander V ^a   Burnett Bowie, Sherri Ann M ^a   Neer, Robert M ^a   Zhu, Yuli ^a   Derrico, Nicholas ^a   Lee, Hang ^a   Bouxsein, Mary L ^a,b   Leder, Benjamin Z ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Denosumab; High Resolution Peripheral Quantitative Computed Tomography; Microarchitecture; Osteoporosis; Teriparatide

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PARATHYROID HORMONE[1-34]; BONE DENSITY CONSERVATION AGENT; MONOCLONAL ANTIBODY;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; BONE STRENGTH; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); DRUG EXPOSURE; FEMALE; HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; HISPANIC; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL HISTORY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RADIUS; RANDOMIZED CONTROLLED TRIAL; TIBIA; TREATMENT RESPONSE; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG EFFECTS; METABOLISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROCEDURES; RADIOGRAPHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DENOSUMAB; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RADIUS; TERIPARATIDE; TIBIA;

EID: 84919905296     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2315     Document Type: Article

References (33)

1. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroidhormone and alendronate alone or in combination in postmenopausalosteoporosis. N Engl J Med. 2003 Sep 25;349(13):1207-15
2. Cosman F, Eriksen EF, Recknor C, et al. Effects of intravenouszoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] inpostmenopausal osteoporosis. J Bone Miner Res. 2011 Mar;26(3):503-11
3. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. Theeffects of parathyroid hormone, alendronate, or both in men withosteoporosis. N Engl J Med. 2003 Sep 25;349(13):1216-26
4. Finkelstein JS, Wyland JJ, Lee H, Neer RM. Effects of teriparatide,alendronate, or both in women with postmenopausal osteoporosis.J Clin Endocrinol Metab. 2010 Apr;95(4):1838-45
5. Tsai JN, Uihlein AV, Lee H, et al. Teriparatide and denosumab, alone orcombined, in women with postmenopausal osteoporosis: the DATAstudy randomised trial. Lancet. 2013 Jul 6;382(9886):50-6
6. Burghardt AJ, Kazakia GJ, Sode M, de Papp AE, Link TM, Majumdar S. Alongitudinal HR-pQCT study of alendronate treatment in postmenopausalwomen with low bone density: relations among density,cortical and trabecular microarchitecture, biomechanics, and boneturnover. J Bone Miner Res. 2010 Dec;25(12):2558-71
7. Seeman E, Delmas PD, Hanley DA, et al. Microarchitecturaldeterioration of cortical and trabecular bone: differing effects ofdenosumab and alendronate. J Bone Miner Res. 2010 Aug;25(8):1886-94
8. Rizzoli R, Laroche M, Krieg MA, et al. Strontium ranelate andalendronate have differing effects on distal tibia bone microstructurein women with osteoporosis. Rheumatol Int. 2010 Aug;30(10):1341-8
9. Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK. Changes intrabecular and cortical bone microarchitecture at peripheral sitesassociated with 18 months of teriparatide therapy in postmenopausalwomen with osteoporosis. Osteoporos Int. 2011 Jan;22(1):357-62
10. Rizzoli R, Chapurlat RD, Laroche JM, et al. Effects of strontium ranelateand alendronate on bone microstructure in women with osteoporosis.Results of a 2-year study. Osteoporos Int. 2012 Jan;23(1):305-15
11. Chapurlat RD, Laroche M, Thomas T, Rouanet S, Delmas PD, deVernejoul MC. Effect of oral monthly ibandronate on bone microarchitecturein women with osteopenia-A randomized placebocontrolledtrial. Osteoporos Int. 2013 Jan;24(1):311-20
12. Hansen S, Hauge EM, Beck Jensen JE, Brixen K. Differing effects of PTH1-34, PTH 1-84, and zoledronic acid on bone microarchitecture andestimated strength in postmenopausal women with osteoporosis: an18-month open-labeled observational study using HR-pQCT. J BoneMiner Res. 2013 Apr;28(4):736-45
13. Bala Y, Chapurlat R, Cheung AM, et al. Risedronate slows or partlyreverses cortical and trabecular microarchitectural deterioration inpostmenopausal women. J Bone Miner Res. 2014 Feb;29(2):380-8
14. Nishiyama KK, Cohen A, Young P, et al. Teriparatide increasesstrength of the peripheral skeleton in premenopausal women withidiopathic osteoporosis: a pilot HR-pQCT study. J Clin EndocrinolMetab. 2014 Mar31:jc20141041
15. McCalden RW, McGeough JA, Barker MB, Court-Brown CM. Agerelatedchanges in the tensile properties of cortical bone. The relativeimportance of changes in porosity, mineralization, and microstructure.J Bone Joint Surg Am. 1993 Aug;75(8):1193-205
16. Bousson V, Meunier A, Bergot C, et al. Distribution of intracorticalporosity in human midfemoral cortex by age and gender. J BoneMiner Res. 2001 Jul;16(7):1308-17
17. Bell KL, Loveridge N, Power J, Garrahan N, Meggitt BF, Reeve J.Regional differences in cortical porosity in the fractured femoral neck.Bone. 1999 Jan;24(1):57-64
18. Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML,Delmas PD. Finite element analysis based on in vivo HR-pQCT imagesof the distal radius is associated with wrist fracture in postmenopausalwomen. J Bone Miner Res. 2008 Mar;23(3):392-9
19. Vilayphiou N, Boutroy S, Sornay-Rendu E, et al. Finite element analysisperformed on radius and tibia HR-pQCT images and fragility fracturesat all sites in postmenopausal women. Bone. 2010 Apr;46(4):1030-7
20. Vilayphiou N, Boutroy S, Szulc P, et al. Finite element analysisperformed on radius and tibia HR-pQCT images and fragility fracturesat all sites in men. J Bone Miner Res. 2011 May;26(5):965-73
21. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitectureand stiffness in postmenopausal women with ankle fractures. J ClinEndocrinol Metab. 2011 Jul;96(7):2041-8
22. Black DM, Steinbuch M, Palermo L, et al. An assessment tool forpredicting fracture risk in postmenopausal women. Osteoporos Int.2001;12(7):519-28
23. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S.Age- and gender-related differences in the geometric properties andbiomechanical significance of intracortical porosity in the distalradius and tibia. J Bone Miner Res. 2010 May;25(5):983-93
24. Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F,Ruegsegger P. Estimation of distal radius failure load with micro-finiteelement analysis models based on three-dimensional peripheralquantitative computed tomography images. Bone. 2002 Jun;30(6):842-8
25. Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK. Reproducibilityof direct quantitative measures of cortical bone microarchitecture ofthe distal radius and tibia by HR-pQCT. Bone. 2010 Sep;47(3):519-28
26. Ma Y, Jee WS, Yuan Z, et al. Parathyroid hormone and mechanicalusage have a synergistic effect in rat tibial diaphyseal cortical bone.J Bone Miner Res. 1999 Mar;14(3):439-48
27. Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM. Anaboliceffects of human biosynthetic parathyroid hormone fragment (1-34),LY333334, on remodeling and mechanical properties of cortical bonein rabbits. J Bone Miner Res. 1999 Apr;14(4):536-45
28. Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM.Intermittently administered human parathyroid hormone(1-34)treatment increases intracortical bone turnover and porosity withoutreducing bone strength in the humerus of ovariectomizedcynomolgus monkeys. J Bone Miner Res. 2001 Jan;16(1):157-65
29. Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY. Effectsof daily treatment with parathyroid hormone 1-84 for 16 months ondensity, architecture and biomechanical properties of cortical bonein adult ovariectomized rhesusmonkeys. Bone. 2007 Sep;41(3):321-30
30. Zebaze R, Ghasem-Zadeh A, Mbala A, Seeman E. A new method ofsegmentation of compact-Appearing, transitional and trabecularcompartments and quantification of cortical porosity from highresolution peripheral quantitative computed tomographic images.Bone. 2013 May;54(1):8-20
31. Zebaze RM, Libanati C, Austin M, et al. Differing effects of denosumaband alendronate on cortical and trabecular bone. Bone. 2014 Feb;59:173-9
32. Pialat JB, Burghardt AJ, Sode M, Link TM, Majumdar S. Visual gradingof motion induced image degradation in high resolution peripheralcomputed tomography: impact of image quality on measures ofbone density and micro-Architecture. Bone. 2012 Jan;50(1):111-8
33. Currey JD. The effect of porosity and mineral content on the Young'smodulus of elasticity of compact bone. J Biomech. 1988;21(2):131-9.